scorecardresearch
Friday, September 5, 2025
TopicBharat Biotech

Topic: Bharat Biotech

Bharat Biotech gets DCGI’s nod to conduct ​clinical trials of intranasal Covid vaccine BBV154

The dosage form of the vaccine is liquid, containing 0.5ml/per dose for the intranasal route of administration. The trials will take place at nine different sites of the country.

Study shows Covaxin booster dose neutralises both Omicron, Delta variants: Bharat Biotech

Bharat Biotech said a study at Emory University demonstrated that people who got a Covaxin booster, 6 months after the two doses, witnessed neutralising of the two Covid variants.

Covaxin booster increases antibody levels by 19-97 fold against Covid variants: Phase 2 results

Study, which is yet to be peer-reviewed, was published on preprint portal medRxiv Saturday. It was conducted by Bharat Biotech and ICMR, which co-developed the vaccine.

Covaxin demonstrates robust safety and immunogenicity in 2-18-year-old volunteers, study says

The data was submitted to the Central Drugs Standard Control Organisation during October 2021 and received emergency use nod for children aged 12-18 from DCGI recently.

Covaxin was 50% effective among health workers in 2nd wave, real-world study from AIIMS shows

Study published in Lancet Infectious Diseases journal assessed 2,714 hospital workers from AIIMS New Delhi, who were most exposed to Covid and were primarily offered Covaxin.

Good news for kids: Expert panel gives Covaxin emergency approval for 2-18-year-olds

The phase 2/3 clinical trials for Covaxin for children were completed last month. The SEC will now send its recommendations to DCGI.

SII, Bharat Biotech get nod to export 10 lakh Covid vaccine doses under ‘Vaccine Maitri’

Ten lakh doses of Covaxin would be sent to Iran and 10 lakh doses of Covishield will be exported each to Myanmar, Nepal & Bangladesh under the ‘Vaccine Maitri’ programme in October.

NCB’s job is narcotics control, not headline mongering

ThePrint view on the most important issues, instantly.

Bharat Biotech vaccine for drug-resistant typhoid found safe, effective for children under 12 

The typhoid fever, caused by H58 Salmonella Typhi, a type of bacteria that has become resistant to multiple drugs, is an increasing public health threat in sub-Saharan Africa.

Bharat Biotech’s Ankleshwar plant, manufacturer of rabies vaccine, rolls out 1st batch of Covaxin

Health Minister Mansukh Mandaviya released the first commercial batch of Covaxin from the Gujarat plant Sunday, said it had the capacity to produce more than 1 crore doses per month.

On Camera

Giorgio Armani brought a feminine touch to men’s tailoring — and taught them how to suit up

Armani built a multibillion-dollar global brand from something as simple as an unstructured jacket, and broke down the walls between formal and casual.

GST 2.0: India streamlines indirect tax regime amid Trump tariffs & what it means for consumers

Goods and Services Tax Council paves way for a broad two-slab structure of 5% and 18% with a demerit rate of 40% for super luxury and 'sin' goods.

HAL team to visit US this month for talks on joint production of GE 414 engines

The engines are meant for Tejas Mk 2 and the first tranche of Advanced Medium Combat Aircraft (AMCA).

For Indian Mercedes, Asim Munir’s dumper truck in mirror is closer than it appears

From Munir’s point of view, a few bumps here and there is par for the course. He isn’t going to drive his dumper truck to its doom. He wants to use it as a weapon.